Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by E. Bosch.
Human Reproduction | 2013
M.J. de los Santos; Virginia García-Láez; Diana Beltrán; E. Labarta; Jose Luis Zuzuarregui; Pilar Alamá; Pilar Gámiz; Juana Crespo; E. Bosch; A. Pellicer
STUDY QUESTION What is the final hormonal milieu of pre-ovulatory follicles of low-responder (LR) patients undergoing unstimulated cycles? SUMMARY ANSWER Neither androgen secretion nor LH was impaired in pre-ovulatory follicles of LR women. WHAT IS KNOWN ALREADY Therapies currently used to improve ovarian response in LR women have an impact on the final hormonal follicular milieu, and these changes are believed to be partially responsible for determining the success rate in these women. Surprisingly, as far as we know, there is no report of the final hormonal profile of LR women undergoing unstimulated cycles or evidence that follicular androgen secretion in LR women is impaired. STUDY DESIGN, SIZE AND DURATION A prospective case-control study including 94 women, 36 normal controls and 58 LR patients (19 Young ≤ 35 years LR and 39 Aged >35 years LR) from 2009 to 2011. PARTICIPANTS/MATERIALS, SETTING AND METHODS Fifty-eight LR women were divided into two groups: Young LR (age ≤ 35; n = 19) and Aged LR (ALR; age >35; n = 39). The control group (group C) comprised 36 egg donors undergoing an unstimulated cycle in our IVF unit. Serum and follicular fluid hormonal concentrations for estradiol (E₂), progesterone, testosterone and androstendione were measured. The spindle parameters of metaphase II oocytes generated from these groups were also analysed. MAIN RESULTS AND THE ROLE OF CHANCE Pre-ovulatory follicles from LR patients had similar androgenic and LH concentrations to those observed in the control group. However, higher intrafollicular concentrations of FSH and progesterone were observed in ALR. Moreover, no differences were found for the spindle evaluation of oocytes between groups by the Oosight technology. LIMITATIONS, REASONS FOR CAUTION The controls were younger and had a lower BMI than the LR women. The sample size available restricted statistical power. WIDER IMPLICATIONS OF THE FINDINGS This study suggests that the problem with LR women is not the final pre-ovulatory follicular androgen concentration since this is similar to normal responders, but in the ability to respond to controlled ovarian stimulation protocols. Therefore, efforts should be focused on long-interval androgen priming to potentially increase the recruitment of small antral follicles rather than increasing the intraovarian androgen levels within the current cycle. STUDY FUNDING/COMPETING INTEREST The present project has been supported by the R+D programme from the Generalitat Valenciana (Regional Valencian Government) IMPIVA MIDTF/2010/95. The authors have no conflict of interest to declare.
Treballs de la Societat Catalana de Biologia | 2008
Sergi Bonet; Maria Dolors Briz González; Elisabeth Pinart Nadal; Sílvia Sancho Badell; Eva Bussalleu Muntada; Marc Yeste Oliveras; Isabel Casas Roqueta; Anna Fábregas; Marta Puigmulé; Estela García; Mónica Santos; E. Bosch; Sílvia Micaló
Reproductive biotechnology in porcine includes several techniques of analysis of the seminal quality and techniques of assisted reproduction. The main goals are guaranteeing the biological security, allowing the traceability and increasing (or stabilizing) the repductive yield. Among the techniques of analysis of the seminal quality we highlight those of sperm quality (concentration, motility, viability, integrity of membranes and DNA), those of sanitary control (PCR-RT for the detection of virus and bacteria) and those of determination of fertilizing ability and osmotic resistance. Among the assisted reproduction techniques, there is artificial insemination (cervical, postcervical and intrauterine), in vitro fertilization, intracytoplasmic injection of spermatozoa, embryonic vitrification, non surgical embryonic transfer, sperm cryopreservation, spermatozoa and embryos sexing, reproductive and therapeutic cloning, and transgenity.
Fertility and Sterility | 2008
E. Bosch; E. Labarta; Carlos Simón; J. Remohí; A. Pellicer
Fertility and Sterility | 2012
E. Labarta; E. Bosch; Amparo Mercader; Pilar Alamá; Emilia Mateu; A. Pellicer
Fertility and Sterility | 2007
E. Labarta; E. Bosch; Carlos Simón; J. Remohí; A. Pellicer
Fertility and Sterility | 2018
E. Bosch; E. Labarta; J. Zuzuarregui; S. Iliodromiti; Scott M. Nelson
Fertility and Sterility | 2015
E. Labarta; Diego Marin; E. Bosch; A. Pellicer; J. Remohí
Human Reproduction | 2011
V. Gallot; A.L. Berwanger da Silva; Vanessa Krebs Genro; Michaël Grynberg; Nelly Frydman; Renato Fanchin; V. Genro; Ursula da Silveira Matte; E. de Conto; João Sabino Cunha-Filho; T. Segawa; S. Teramoto; T. Ohkubo; T. Ueno; T. Hayashi; M. Shozu; H.I. Hanevik; H.T. Hilmarsen; C.F. Skjelbred; T. Tanbo; J.A. Kahn; M.J. de los Santos; Virginia García-Láez; E. Labarta; J. Zuzuarregui; Pilar Gámiz; E. Bosch; A. Pellicer
Fertility and Sterility | 2011
M.-H. Racicot; E. Labarta; Ana Cobo; E. Bosch; A. Pellicer; J. Remohí
Fertility and Sterility | 2010
E. Labarta; Laura Privitera; E. Bosch; Amparo Ruiz; J. Remohí; A. Pellicer